Chiron Capital Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-9,500
| Closed | -$236K | – | 127 |
|
|
2023
Q2 | $236K | Sell |
9,500
-2,600
| -21% | -$64.6K | 0.19% | 91 |
|
|
2023
Q1 | $182K | Buy |
12,100
+1,483
| +14% | +$22.3K | 0.13% | 113 |
|
|
2022
Q4 | $126K | Buy |
+10,617
| New | +$126K | 0.09% | 117 |
|
|
2022
Q3 | – | Sell |
-10,717
| Closed | -$46K | – | 130 |
|
|
2022
Q2 | $46K | Sell |
10,717
-2,975
| -22% | -$12.8K | 0.03% | 125 |
|
|
2022
Q1 | $130K | Buy |
13,692
+1,920
| +16% | +$18.2K | 0.08% | 118 |
|
|
2021
Q4 | $224K | Buy |
+11,772
| New | +$224K | 0.16% | 102 |
|
|
2020
Q4 | – | Sell |
-4,425
| Closed | -$118K | – | 402 |
|
|
2020
Q3 | $118K | Buy |
+4,425
| New | +$118K | 0.1% | 96 |
|